Crowdsourced AI learns to target lung tumors for radiation

( Reuters Health) – In lots of parts of the world there are insufficient radiation oncologists to develop and provide radiation treatments for lung cancer clients, however that space might one day be filled with the assistance of expert system, scientists recommend in a brand-new research study. In an unique technique to the issue, the … Read more

Breast cancer: Reducing this amino acid could make drugs more effective

Leucine, an amino acid that the body requires for making protein, appears to have an unexpected function in the advancement of resistance to tamoxifen in breast cancer that evaluates favorable for the estrogen receptor. New research study in cell cultures discovers that lower levels of dietary leucine might enhance the efficiency of cancer drugs. Researchers … Read more

Alternative therapies for cancer: Do they do more harm than good?

Brand-new research study discovers that one-third of individuals dealing with cancer usage complementary and alternative treatments. Physician raise issues about the security of these practices, recommending that they might disrupt traditional cancer treatment. New research study recommends that yoga might be among the couple of nonconventional treatments that might assist individuals dealing with cancer. In … Read more

HMS researchers design algorithm that ID’s DNA defects, making more cancers treatable

Discovering DNA problems. A brand-new algorithm can be included into basic hereditary tests to recognize clients harboring a tumor-fueling DNA repair work problem discovered in several cancers treatable with existing drugs. Imagined is a 3-D illustration of a DNA hair and cancer cell. iStock HMS Researchers style algorithm able to ID formerly evasive cancers Medications … Read more

Hundreds of new anti-cancer drug targets identified using CRISPR

A team of scientists from the Wellcome Sanger Institute have identified the genes that are essential for the survival of thirty types of cancer cells. The resultant cancer dependency map will facilitate the development of novel targeted cancer treatments. The study, which is entitled “Prioritization of cancer therapeutic targets using CRISPR–Cas9 screens”, was published in … Read more

Cancer: Novel cell death technique may be better than chemo

Chemotherapy, radiotherapy, and immunotherapy are typically used to treat cancer, but they do not work for all patients with the disease. In a new study, scientists have discovered a cancer-killing technique that might be more effective than conventional cancer therapies.Researchers have discovered a potentially more effective way to kill cancer cells. Researchers reveal how a … Read more

Study describes vulnerability shared by large subset of cancer cell lines

Cancer cells adapt to potentially fatal mutations and other molecular malfunctions by adjusting one or more other genes' activity, in the process becoming dependent on those genes for their survival and growth. The resulting genetic dependencies may provide targets for developing new precision-guided drugs or other cancer treatment strategies. Reporting in Nature, researchers led by … Read more

US FDA approves Johnson & Johnson’s bladder cancer drug

The U.S. Food and Drug Administration on Friday approved Johnson & Johnson’s treatment for patients with a form of bladder cancer. FILE PHOTO: A Johnson & Johnson building is shown in Irvine, California, U.S., January 24, 2017. REUTERS/Mike Blake REUTERS: The U.S. Food and Drug Administration on Friday approved Johnson & Johnson’s treatment for patients … Read more

Top cancer hospitals’ outcomes may be better than affiliates’

(Reuters Health) – Patients often assume that surgical outcomes at all hospitals in a healthcare network are equally good. But a new study comparing outcomes from top-ranked cancer hospitals to their affiliates finds significant differences when it comes to complex cancer surgeries. Researchers found that the likelihood of surviving a complex cancer surgery was greater … Read more

Clovis Oncology halts mid-stage bladder cancer trial, shares drop

REUTERS: Clovis Oncology Inc said on Friday (Apr 12) it was halting a mid-stage trial testing its lead drug in bladder cancer patients, sending shares down 12 per cent. The company said its decision to discontinue the trial was based on recommendations of an independent committee, which suggested that the treatment may not provide a … Read more

Translate »